A morphometric study of bone marrow angiogenesis in hairy cell leukaemia with clinicopathological correlations
Open Access
- 3 September 2003
- journal article
- website
- Published by Wiley in British Journal of Haematology
- Vol. 122 (6) , 900-910
- https://doi.org/10.1046/j.1365-2141.2003.04527.x
Abstract
Summary. Bone marrow angiogenesis has recently been implicated in the pathophysiology and course of various haematological malignancies. Little is known, however, about the significance of this phenomenon in hairy cell leukaemia (HCL). We evaluated various morphometric characteristics of microvessels, highlighted by means of anti‐CD34 immunohistochemistry, in the bone marrow of 44 patients with typical HCL, before and after treatment with interferon‐α (IFN‐α). Overall, bone marrow from 103 HCL patients and 20 controls was examined. Microvessel density (MVD) and several size‐ and shape‐related parameters were quantified in the region of most intense vascularization using image analysis. MVD, size‐related parameters and the percentage of branching microvessels were higher in HCL than in controls. Likewise, perimeter counts were higher in partial/non‐responders than in complete responders. Achievement of complete response was accompanied by smaller calibre microvessels. IFN‐α induced a decrease in MVD and branching values in cases with diffuse marrow involvement. In univariate analysis, progression‐free survival was adversely affected by MVD, branching and major axis length. Multivariate analysis indicated that MVD/branching independently affected progression‐free survival and the likelihood of complete response. Our data suggest that the generation of bone marrow microvessels indicated an increased risk of progression and IFN‐α treatment failure in HCL. Furthermore, the prognostic significance of angiogenesis requires the concomitant assessment of MVD and the complexity of the microvascular network.Keywords
This publication has 34 references indexed in Scilit:
- Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial growth factorBritish Journal of Haematology, 2001
- In vitro and in vivo production of vascular endothelial growth factor by chronic lymphocytic leukemia cellsBlood, 2000
- Angiogenesis in acute and chronic leukemias and myelodysplastic syndromesBlood, 2000
- Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemiaBlood, 2000
- Current Status Of Antiangiogenic FactorsBritish Journal of Haematology, 2000
- Cellular Vascular Endothelial Growth Factor Is a Predictor of Outcome in Patients With Acute Myeloid LeukemiaBlood, 1999
- Basic Fibroblast Growth Factor Is Expressed by CD19/CD11c-Positive Cells in Hairy Cell LeukemiaBlood, 1999
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisPublished by Elsevier ,1996
- Clinical Applications of Research on AngiogenesisNew England Journal of Medicine, 1995
- Predictors of pathologic stage in prostatic carcinoma. The role of neovascularityCancer, 1994